PMID- 32887213 OWN - NLM STAT- MEDLINE DCOM- 20201208 LR - 20201214 IS - 1660-4601 (Electronic) IS - 1661-7827 (Print) IS - 1660-4601 (Linking) VI - 17 IP - 17 DP - 2020 Sep 2 TI - Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study. LID - 10.3390/ijerph17176378 [doi] LID - 6378 AB - Polypoidal choroidal vasculopathy (PCV), a subtype of neovascular age-related macular degeneration, requires repeated treatment. The objective of this pilot study was to evaluate and compare vision-targeted quality of life (QOL) at baseline and after 6 months of treatment in patients with PCV. Naive PCV patients were recruited. Visual functions assessed were distance visual acuity (DVA), near visual acuity (NVA), contrast sensitivity (CS), reading speed (RS), and QOL at baseline and after 6 months of treatment. Thirty patients (average age of 67.62 +/- 8.05 years) revealed mean DVA and NVA improvements of 0.24 logMAR and 0.30 logMAR, respectively. Mean CS and RS improved by 0.39 log contrast and 25.58 words per minute, respectively. The National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25) composite score significantly increased from a baseline of 66.73 +/- 13.74 to 73.54 +/- 14.26. Twenty-eight of the patients showed overall improvement in QOL score by 5 units or more or remained stable. Subscales of NEI-VFQ-25 significantly improved, with general vision, mental health, and role difficulties improving by 10 or more units. The present pilot study reports a significant improvement of QOL in PCV patients after 6 months of treatment, with mental health, role difficulties, social functioning, and distance vision activities being the most improved subscales. FAU - Ghoshal, Rituparna AU - Ghoshal R AD - Optometry and Vision Science Program, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia. AD - Department of Optometry, Supreme Institute of Management and Technology, Mankundu Hooghly, West Bengal 712123, India. FAU - Sharanjeet-Kaur, Sharanjeet AU - Sharanjeet-Kaur S AUID- ORCID: 0000-0003-0734-5151 AD - Optometry and Vision Science Program, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia. FAU - Fadzil, Norliza Mohamad AU - Fadzil NM AD - Optometry and Vision Science Program, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia. FAU - Ghosh, Somnath AU - Ghosh S AD - Department of Allied Health Sciences, Brainware University, Barasat, Kalkata, West Bengal 700125, India. FAU - Ngah, Nor Fariza AU - Ngah NF AD - Department of Ophthalmology, Hospital Shah Alam, Persiaran Kayangan, Seksyen 7, Shah Alam 40000, Selangor, Malaysia. FAU - Aziz, Roslin Azni Abd AU - Aziz RAA AD - Department of Ophthalmology, Hospital Shah Alam, Persiaran Kayangan, Seksyen 7, Shah Alam 40000, Selangor, Malaysia. LA - eng PT - Journal Article DEP - 20200902 PL - Switzerland TA - Int J Environ Res Public Health JT - International journal of environmental research and public health JID - 101238455 SB - IM MH - Aged MH - Humans MH - *Macular Degeneration/therapy MH - Middle Aged MH - Patient Satisfaction MH - Pilot Projects MH - *Quality of Life MH - Surveys and Questionnaires MH - Visual Acuity PMC - PMC7504237 OTO - NOTNLM OT - patient-perceived treatment outcome OT - polypoidal choroidal vasculopathy OT - vision-targeted quality of life COIS- The authors declare no conflict of interest. EDAT- 2020/09/06 06:00 MHDA- 2020/12/15 06:00 PMCR- 2020/09/01 CRDT- 2020/09/05 01:03 PHST- 2020/07/15 00:00 [received] PHST- 2020/08/03 00:00 [revised] PHST- 2020/08/04 00:00 [accepted] PHST- 2020/09/05 01:03 [entrez] PHST- 2020/09/06 06:00 [pubmed] PHST- 2020/12/15 06:00 [medline] PHST- 2020/09/01 00:00 [pmc-release] AID - ijerph17176378 [pii] AID - ijerph-17-06378 [pii] AID - 10.3390/ijerph17176378 [doi] PST - epublish SO - Int J Environ Res Public Health. 2020 Sep 2;17(17):6378. doi: 10.3390/ijerph17176378.